• Latest Posts

After being rejected twice, Horizon pushes Depomed to accept its €2.7Bn offer

Alexion will invest €450 million to expand to Dublin

Sygnis on the way to conquer the UK Life Sciences market

Heart Metabolics bargain with the FDA for a single Phase III

Alkermes presents its new treatment of Alzheimer’s agitation

ICON Completes the Acquisition of MediMedia Pharma Solutions

ADVERTISEMENT

Will New Actavis-Allergan Entity Lead to Be in the World Top 10 Drugmakers Companies?

ADVERTISEMENT